Limula
Proposes a closed and automated cell therapy manufacturing platform that operates at the point of care.
Launch date
Employees
Market cap
-
Enterprise valuation
€25—37m (Dealroom.co estimates May 2024.)
Company register number CHE-409.279.000
Epalinges Canton of Vaud (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Grant | |
* | CHF250k | Grant | |
* | CHF90.0k | Grant | |
* | N/A | - | |
* | $6.8m | Seed | |
| Total Funding | €11.2m | ||
Related Content
Recent News about Limula
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.